Log In
Print this Print this

Chimigen MUC 1 cancer vaccine

  Manage Alerts
Collapse Summary General Information
Company Akshaya Bio Inc.
DescriptionVaccine targeting mucin 1 (MUC1; CD227)
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat MUC1-expressing cancers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today